Ignite Creation Date:
2025-12-24 @ 10:32 PM
Ignite Modification Date:
2025-12-25 @ 8:05 PM
Study NCT ID:
NCT02269735
Status:
COMPLETED
Last Update Posted:
2019-01-15
First Post:
2014-10-16
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Three-part Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of MK-2640 in Healthy Participants (Part I) and Participants With Type 1 Diabetes Mellitus (Parts II and III) (MK-2640-001)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-11-26
Start Date Type:
ACTUAL
Primary Completion Date:
2016-07-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-07-29
Completion Date Type:
ACTUAL
First Submit Date:
2014-10-16
First Submit QC Date:
None
Study First Post Date:
2014-10-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-01-11
Last Update Post Date:
2019-01-15
Last Update Post Date Type:
ACTUAL